Between January 1995 and March 2002, 120 patients with NHL received progenitor cell mobilisation with CY 4 g/m 2 followed by G-CSF and came to our unit for progenitor cell aphaeresis. The patient ...
Please provide your email address to receive an email when new articles are posted on . High dose early mobilization is not recommended for those with diabetes in the ICU. A larger proportion of ...
The recent FDA approval of Aphexda combined with filgrastim improved the collection of stem cells in patients with multiple myeloma. Stem cell transplantation is an important treatment method for ...
ATS 2009, SAN DIEGO—Aside from the obvious and immediate health problems that patients undergoing mechanical ventilation face, those who recover often do so with profound loss of strength and mobility ...
INDIANAPOLIS (WISH) — Brian Stockman, the clinical director at Team Rehabilitation Facility in Broad Ripple, is helping patients recover from surgeries like total knee replacements through ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed patient ...
Consistent Trophoblast Cell Surface Antigen 2 Positivity in Tracheobronchial Adenoid Cystic Carcinoma: Expanding Antibody-Drug Conjugate Opportunities in Rare Thoracic Tumor We conducted a ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results